Katherine Michaelis

7PUBLICATIONS
19CO-AUTHORS
Molecular targetsPredictive and prognostic markersCancer cell biologyCancer therapy (excl. chemotherapy and radiation therapy)Cancer diagnosis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Sep 02, 2026
PTPN2 Deletion Enhances CAR-T Effector Function and CNS Trafficking in a Non-Human Primate Model.

|Sep 26, 2025
PTPN2-KO CAR-T Cells Demonstrate Enhanced Effector Function, CNS Infiltration, and Toxicity in a Non-Human Primate CAR-T Model.

Francesca Alvarez Calderon, Ryan A Fleming, Marlana Winschel

|Apr 07, 2021
Lipocalin 2 mediates appetite suppression during pancreatic cancer cachexia.

Brennan Olson, Xinxia Zhu, Mason A Norgard

|May 12, 2020
Circulating myeloid cells invade the central nervous system to mediate cachexia during pancreatic cancer.

Kevin G Burfeind, Xinxia Zhu, Mason A Norgard

|Nov 16, 2019
Publisher Correction: The TLR7/8 agonist R848 remodels tumor and host responses to promote survival in pancreatic cancer.

Katherine A Michaelis, Mason A Norgard, Xinxia Zhu

|Oct 17, 2019
The TLR7/8 agonist R848 remodels tumor and host responses to promote survival in pancreatic cancer.

Katherine A Michaelis, Mason A Norgard, Xinxia Zhu

Pageof 2

Frequent Collaborators

4 joint publications

Daniel L Marks

2 joint publications

H Carlo Maurer

2 joint publications

Lorenzo Cagnin

2 joint publications

Kayleigh Ingersoll Omdahl